Chemoinformaics analysis of Linalyl anthranilate
Molecular Weight | 273.376 | nRot | 6 |
Heavy Atom Molecular Weight | 250.192 | nRig | 9 |
Exact Molecular Weight | 273.173 | nRing | 1 |
Solubility: LogS | -4.561 | nHRing | 0 |
Solubility: LogP | 4.419 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 1 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 23 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
nHA | 3 | APOL | 46.4302 |
nHD | 1 | BPOL | 25.1078 |
QED | 0.482 |
Synth | 3.125 |
Natural Product Likeliness | 1.435 |
NR-PPAR-gamma | 0.02 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.192 |
Pgp-sub | 0.002 |
HIA | 0.004 |
CACO-2 | -4.438 |
MDCK | 0.0000262 |
BBB | 0.592 |
PPB | 0.874889 |
VDSS | 1.815 |
FU | 0.0932956 |
CYP1A2-inh | 0.888 |
CYP1A2-sub | 0.27 |
CYP2c19-inh | 0.943 |
CYP2c19-sub | 0.648 |
CYP2c9-inh | 0.659 |
CYP2c9-sub | 0.494 |
CYP2d6-inh | 0.857 |
CYP2d6-sub | 0.283 |
CYP3a4-inh | 0.924 |
CYP3a4-sub | 0.222 |
CL | 9.835 |
T12 | 0.103 |
hERG | 0.017 |
Ames | 0.011 |
ROA | 0.029 |
SkinSen | 0.737 |
Carcinogencity | 0.088 |
EI | 0.958 |
Respiratory | 0.672 |
NR-Aromatase | 0.521 |
Antiviral | Yes |
Prediction | 0.760056 |